Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
MSI-H/dMMR + PD-1 expression + CD8 positive
i
Other names:
MSI | Microsatellite instability, PD1, Programmed Cell Death Protein 1, CD279, SLEB2, PD-1, Programmed cell death 1, PDCD1, Systemic Lupus Erythematosus Susceptibility 2, CD8, CD8A, cluster of differentiation 8, CD8a Molecule, T-Cell Surface Glycoprotein CD8 Alpha Chain, T-Lymphocyte Differentiation Antigen T8/Leu-2, CD8 Antigen, Alpha Polypeptide (P32), Leu2 T-Lymphocyte Antigen, OKT8 T-Cell Antigen, T-Cell Antigen Leu2, T Cell Co-Receptor, T8 T-Cell Antigen, CD8a Antigen
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
925
;
5133
Related biomarkers:
Expression
Mutation
Others
‹
MSI-H/dMMR (182)
MSI-H/dMMR + TMB-H (8)
MSI-L/dMMR (6)
MSI-H/dMMR + TMB-L (5)
PTEN mutation + MSI-H/dMMR (5)
MSI-H/dMMR + POLE mutation (4)
ARID1A mutation + MSI-H (3)
MSI-H/dMMR + MLH1 deletion + PMS2 deletion (3)
MSI-H/dMMR + TMB-H + PD-L1 negative (3)
BRAF V600E + MSI-H (2)
BRAF V600E + PIK3CA mutation + SMAD4 mutation + MSI-H/dMMR (2)
MSI-H/dMMR + TMB-H + PD-L1 overexpression (2)
MSI-L/dMMR + KRAS G12V (2)
CD8-H (2)
PD-1 elevation (2)
PD-1-L (2)
PD-1-L + PD-L1 elevation (2)
B2M mutation + MSI-H/dMMR (1)
BRAF mutation + TMB-L + MSI-L/dMMR (1)
ER positive + MLH1 1835del3 + MSI-H/dMMR + TMB-H (1)
JAK1 mutation + MSI-H/dMMR (1)
JAK2 mutation + MSI-H/dMMR (1)
KRAS wild-type + NRAS wild-type + MSI-H/dMMR (1)
MLH1 methylation + MSI-H/dMMR (1)
MLH1 methylation + MSI-H/dMMR + TMB-H (1)
MSH6 mutation + MLH1 mutation + MSI-H (1)
MSI-H + HER-2 amplification (1)
MSI-H + MSH2 expression + MSH6 expression (1)
MSI-H/dMMR + BRAF Mutation (1)
MSI-H/dMMR + HER-2 mutation (1)
MSI-H/dMMR + KDR overexpression (1)
MSI-H/dMMR + KRAS Mutation (1)
MSI-H/dMMR + KRAS wild-type + BRAF wild-type (1)
MSI-H/dMMR + MLH1 negative + PMS2 negative (1)
MSI-H/dMMR + NTRK1 fusion (1)
MSI-H/dMMR + NTRK2 fusion (1)
MSI-H/dMMR + NTRK3 fusion (1)
MSI-H/dMMR + RAS mutation (1)
MSI-H/dMMR + TP53 mutation (1)
NOTCH1 mutation + TMB-L + MSI-L/dMMR (1)
PD-L1 expression + MSI-H/dMMR (1)
PIK3CA E542Q + TMB-H + MSI-H/dMMR (1)
SMARCA4 deletion + dMMR/MSI-H + PD-L1 underexpression (1)
TMB-H + PD-L1 expression + MSI-L/dMMR (1)
CD8 elevation + BRAF V600 (1)
KRAS mutation + TP53 mutation + PD-L1 expression + PD-1 expression (1)
AKT1 E17K + CTNNB1 G34R + ER Y537S + MSI-H (0)
MSI-H/dMMR + RAS wild-type (0)
MSI-L/dMMR + SMAD4 mutation (0)
PIK3CA mutation + TMB-L + MSI-L/dMMR (0)
MSI-H/dMMR (182)
MSI-H/dMMR + TMB-H (8)
MSI-L/dMMR (6)
MSI-H/dMMR + TMB-L (5)
PTEN mutation + MSI-H/dMMR (5)
MSI-H/dMMR + POLE mutation (4)
ARID1A mutation + MSI-H (3)
MSI-H/dMMR + MLH1 deletion + PMS2 deletion (3)
MSI-H/dMMR + TMB-H + PD-L1 negative (3)
BRAF V600E + MSI-H (2)
BRAF V600E + PIK3CA mutation + SMAD4 mutation + MSI-H/dMMR (2)
MSI-H/dMMR + TMB-H + PD-L1 overexpression (2)
MSI-L/dMMR + KRAS G12V (2)
CD8-H (2)
PD-1 elevation (2)
PD-1-L (2)
PD-1-L + PD-L1 elevation (2)
B2M mutation + MSI-H/dMMR (1)
BRAF mutation + TMB-L + MSI-L/dMMR (1)
ER positive + MLH1 1835del3 + MSI-H/dMMR + TMB-H (1)
JAK1 mutation + MSI-H/dMMR (1)
JAK2 mutation + MSI-H/dMMR (1)
KRAS wild-type + NRAS wild-type + MSI-H/dMMR (1)
MLH1 methylation + MSI-H/dMMR (1)
MLH1 methylation + MSI-H/dMMR + TMB-H (1)
MSH6 mutation + MLH1 mutation + MSI-H (1)
MSI-H + HER-2 amplification (1)
MSI-H + MSH2 expression + MSH6 expression (1)
MSI-H/dMMR + BRAF Mutation (1)
MSI-H/dMMR + HER-2 mutation (1)
MSI-H/dMMR + KDR overexpression (1)
MSI-H/dMMR + KRAS Mutation (1)
MSI-H/dMMR + KRAS wild-type + BRAF wild-type (1)
MSI-H/dMMR + MLH1 negative + PMS2 negative (1)
MSI-H/dMMR + NTRK1 fusion (1)
MSI-H/dMMR + NTRK2 fusion (1)
MSI-H/dMMR + NTRK3 fusion (1)
MSI-H/dMMR + RAS mutation (1)
MSI-H/dMMR + TP53 mutation (1)
NOTCH1 mutation + TMB-L + MSI-L/dMMR (1)
PD-L1 expression + MSI-H/dMMR (1)
PIK3CA E542Q + TMB-H + MSI-H/dMMR (1)
SMARCA4 deletion + dMMR/MSI-H + PD-L1 underexpression (1)
TMB-H + PD-L1 expression + MSI-L/dMMR (1)
CD8 elevation + BRAF V600 (1)
KRAS mutation + TP53 mutation + PD-L1 expression + PD-1 expression (1)
AKT1 E17K + CTNNB1 G34R + ER Y537S + MSI-H (0)
MSI-H/dMMR + RAS wild-type (0)
MSI-L/dMMR + SMAD4 mutation (0)
PIK3CA mutation + TMB-L + MSI-L/dMMR (0)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
MSI-H/dMMR + PD-1 expression + CD8 positive
Cholangiocarcinoma
MSI-H/dMMR + PD-1 expression + CD8 positive
Cholangiocarcinoma
pembrolizumab
Sensitive: C4 – Case Studies
pembrolizumab
Sensitive
:
C4
pembrolizumab
Sensitive: C4 – Case Studies
pembrolizumab
Sensitive
:
C4
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.